'Tax pharma companies if they fail to act on AMR', says Review chief Lord O'Neill.
出版信息
Vet Rec. 2018 Jun 30;182(26):728. doi: 10.1136/vr.k2835.
DOI:10.1136/vr.k2835
PMID:29954991
Abstract
摘要
相似文献
1
'Tax pharma companies if they fail to act on AMR', says Review chief Lord O'Neill.审查负责人奥尼尔勋爵表示，如果制药公司在抗微生物药物耐药性问题上不作为，就要对其征税。
Vet Rec. 2018 Jun 30;182(26):728. doi: 10.1136/vr.k2835.
2
'Ditch the blame culture to tackle AMR'.摒弃指责文化以应对抗菌药物耐药性
Vet Rec. 2019 May 25;184(21):636. doi: 10.1136/vr.l3119.
3
'Remarkable year' for tackling antimicrobial resistance.应对抗微生物药物耐药性的“非凡之年”。
Vet Rec. 2017 Dec;181(22):579. doi: 10.1136/vr.j5589.
4
Jim O'Neill.吉姆·奥尼尔
Nat Rev Drug Discov. 2016 Jul 29;15(8):526. doi: 10.1038/nrd.2016.160.
5
The antimicrobial crisis: enough advocacy, more action.抗菌危机：宣传已足够，行动需更多。
Lancet. 2020 Jan 25;395(10220):247. doi: 10.1016/S0140-6736(20)30119-7.
6
Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance.反思奥尼尔抗微生物药物耐药性审查的最终报告。
Lancet Infect Dis. 2016 Jul;16(7):767-768. doi: 10.1016/S1473-3099(16)30127-X. Epub 2016 May 18.
7
The drug push.毒品贩卖
Science. 2015 May 22;348(6237):850-3. doi: 10.1126/science.348.6237.850.
8
Report urges controversial 'delinkage' to foster new antibiotics.报告敦促进行有争议的“脱钩”以促进新型抗生素的研发。
Nat Med. 2014 Apr;20(4):320. doi: 10.1038/nm0414-320.
9
Vets' responsibility to tackle antimicrobial resistance.兽医应对抗菌药物耐药性的责任。
Vet Rec. 2017 Nov 18;181(20):542. doi: 10.1136/vr.j5298.
10
Pay drug companies $1bn for each new antibiotic, says report.报告称，为每种新型抗生素向制药公司支付10亿美元。
BMJ. 2016 May 19;353:i2863. doi: 10.1136/bmj.i2863.
Zotero 插件